|
|
41
|
|
|
4181B
|
|
|
AVASTIN 25MG/ML INJ (ROC) BEVACIZUMAB (C)
|
|
|
BEVACIZUMAB
|
|
|
AVASTIN
|
|
|
400MG VIAL
|
|
|
C
|
|
|
4012.25
|
|
|
4012.2462
|
|
|
25MG/ML
|
|
|
VIAL
|
|
|
0
|
|
|
VIAL
|
|
|
ROC
|
|
|
ROCHE SERVICIOS S.A.
|
|
|
AHI
|
|
|
ARMSTRONG HEALTHCARE INC
|
|
|
|
|
|
|
|
|
2024-04-01
|
|
|
2026-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
N
|
|
|
1000
|
|
|
ANTINEOPLASTICS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
ANTINEOPLASTICS
|
|
|
|